Abd-Allah NA, Ibrahim OM, Elmalt HA, Shehata MA, Hamed RA, Elsaadouni NM, Hawary B (2020) Thioredoxin level and inflammatory markers in children with autism spectrum disorders. Middle East Curr Psychiatry 27:1–7

Article  Google Scholar 

Abdel-Haq M, Ojha SK, Hamoudi W, Kumar A, Tripathi MK, Khaliulin I, Domb AJ, Amal H (2023) Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism. Nitric Oxide 140–141:41–49

Article  PubMed  Google Scholar 

Akterin S, Cowburn RF, Miranda-Vizuete A, Jiménez A, Bogdanovic N, Winblad B, Cedazo-Minguez A (2006) Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer’s disease. Cell Death Differ 13(9):1454–1465

Article  CAS  PubMed  Google Scholar 

Amal H, Gong G, Gjoneska E, Lewis SM, Wishnok JS, Tsai LH, Tannenbaum SR (2019) S-nitrosylation of E3 ubiquitin-protein ligase RNF213 alters non-canonical Wnt/Ca+2 signaling in the P301S mouse model of tauopathy. Transl Psychiatry 9(1):44

Article  PubMed  PubMed Central  Google Scholar 

Amal H, Barak B, Bhat V, Gong G, Joughin BA, Wang X, Wishnok JS, Feng G, Tannenbaum SR (2020a) Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function. Mol Psychiatry 25(8):1835–1848

Article  CAS  PubMed  Google Scholar 

Amal H, Gong G, Yang H, Joughin BA, Wang X, Knutson CG, Kartawy M, Khaliulin I, Wishnok JS, Tannenbaum SR (2020b) Low doses of arsenic in a mouse model of human exposure and in neuronal culture lead to S-nitrosylation of synaptic proteins and apoptosis via nitric oxide. Int J Mol Sci 21(11):3948

Arodin L, Miranda-Vizuete A, Swoboda P, Fernandes AP (2014) Protective effects of the thioredoxin and glutaredoxin systems in dopamine-induced cell death. Free Radic Biol Med 73:328–336

Article  CAS  PubMed  Google Scholar 

Bandookwala M, Sengupta P (2020) 3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases. Int J Neurosci 130(10):1047–1062

Article  CAS  PubMed  Google Scholar 

Baribeau D, Anagnostou E (2022) Novel treatments for autism spectrum disorder based on genomics and systems biology. Pharmacol Ther 230:107939

Article  CAS  PubMed  Google Scholar 

Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3(3):205–214

Article  CAS  PubMed  Google Scholar 

Benhar M (2015) Nitric oxide and the thioredoxin system: a complex interplay in redox regulation. Biochim Biophys Acta 1850(12):2476–2484

Article  CAS  PubMed  Google Scholar 

Benhar M, Forrester MT, Hess DT, Stamler JS (2008) Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 320(5879):1050–1054

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bjørklund G, Meguid NA, El-Bana MA, Tinkov AA, Saad K, Dadar M, Hemimi M, Skalny AV, Hosnedlová B, Kizek R, Osredkar J, Urbina MA, Fabjan T, El-Houfey AA, Kałużna-Czaplińska J, Gątarek P, Chirumbolo S (2020a) Oxidative stress in autism spectrum disorder. Mol Neurobiol 57(5):2314–2332

Article  PubMed  Google Scholar 

Bjørklund G, Meguid NA, El-Bana MA, Tinkov AA, Saad K, Dadar M, Hemimi M, Skalny AV, Hosnedlová B, Kizek R (2020b) Oxidative stress in autism spectrum disorder. Mol Neurobiol 57:2314–2332

Bjørklund G, Zou L, Peana M, Chasapis CT, Hangan T, Lu J, Maes M (2022) The role of the thioredoxin system in brain diseases. Antioxidants 11(11):2161

Article  PubMed  PubMed Central  Google Scholar 

Bórquez DA, Urrutia PJ, Wilson C, van Zundert B, Núñez MT, González-Billault C (2016) Dissecting the role of redox signaling in neuronal development. J Neurochem 137(4):506–517

Article  PubMed  Google Scholar 

Bossolani-Martins A, Rodrigues-Lisoni F, Nogueira M et al (2010) Molecular evaluation of exons 8 and 22 of the SHANK3 gene in Autism Spectrum Disorders. Nat Prec. https://doi.org/10.1038/npre.2010.4200.1

Cebula M, Schmidt EE, Arnér ES (2015) TrxR1 as a potent regulator of the Nrf2-Keap1 response system. Antioxid Redox Signal 23(10):823–853

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chauhan A, Chauhan V (2006) Oxidative stress in autism. Pathophysiology 13(3):171–181

Article  CAS  PubMed  Google Scholar 

Chen X, Guo C, Kong J (2012) Oxidative stress in neurodegenerative diseases. Neural Regen Res 7(5):376

CAS  PubMed  PubMed Central  Google Scholar 

Christensen DL, Maenner MJ, Bilder D, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Pettygrove SD, Robinson C, Shenouda J, White T, Zahorodny W, Pazol K, Dietz P (2019) Prevalence and characteristics of autism spectrum disorder among children aged 4 years - early autism and developmental disabilities monitoring network, seven sites, United States, 2010, 2012, and 2014. MMWR Surveill Summ 68(2):1–19

Article  PubMed  PubMed Central  Google Scholar 

Coley AA, Gao WJ (2018) PSD95: a synaptic protein implicated in schizophrenia or autism? Prog Neuropsychopharmacol Biol Psychiatry 82:187–194

Article  CAS  PubMed  Google Scholar 

Dawson VL, Dawson TM (1996) Nitric oxide neurotoxicity. J Chem Neuroanat 10(3–4):179–190

Article  CAS  PubMed  Google Scholar 

De Bruycker S, Vangestel C, Van den Wyngaert T, Wyffels L, Wouters A, Pauwels P, Staelens S, Stroobants S (2016) Baseline [(18)F]FMISO μPET as a predictive biomarker for response to HIF-1α inhibition combined with 5-FU chemotherapy in a human colorectal cancer xenograft model. Mol Imaging Biol 18(4):606–616

Article  PubMed  Google Scholar 

Dodson M, de la Vega MR, Cholanians AB, Schmidlin CJ, Chapman E, Zhang DD (2019) Modulating NRF2 in disease: timing is everything. Annu Rev Pharmacol Toxicol 59:555–575

Article  CAS  PubMed  Google Scholar 

Drapeau E, Riad M, Kajiwara Y, Buxbaum JD (2018) Behavioral phenotyping of an improved mouse model of Phelan–McDermid syndrome with a complete deletion of the Shank3 gene. Eneuro 5(3)

Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem 267(16):4912–4916

Article  CAS  PubMed  Google Scholar 

Durand CM, Perroy J, Loll F, Perrais D, Fagni L, Bourgeron T, Montcouquiol M, Sans N (2012) SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol Psychiatry 17(1):71–84

Article  CAS  PubMed  Google Scholar 

Džoljić E, Grbatinić I, Kostić V (2015) Why is nitric oxide important for our brain? Funct Neurol 30(3):159–163

PubMed  PubMed Central  Google Scholar 

Fatemi SH, Aldinger KA, Ashwood P, Bauman ML, Blaha CD, Blatt GJ, Chauhan A, Chauhan V, Dager SR, Dickson PE, Estes AM, Goldowitz D, Heck DH, Kemper TL, King BH, Martin LA, Millen KJ, Mittleman G, Mosconi MW, Persico AM, Sweeney JA, Webb SJ, Welsh JP (2012) Consensus paper: pathological role of the cerebellum in autism. Cerebellum 11(3):777–807

Article  PubMed  PubMed Central  Google Scholar 

Gettayacamin M, Retnam L (2017) AAALAC international standards and accreditation process. Toxicol Res 33:183–189

Article  PubMed  PubMed Central  Google Scholar 

Go YM, Orr M, Jones DP (2013) Increased nuclear thioredoxin-1 potentiates cadmium-induced cytotoxicity. Toxicol Sci 131(1):84–94

Article  CAS  PubMed  Google Scholar 

Go YM, Son DJ, Park H, Orr M, Hao L, Takabe W, Kumar S, Kang DW, Kim CW, Jo H, Jones DP (2014) Disturbed flow enhances inflammatory signaling and atherogenesis by increasing thioredoxin-1 level in endothelial cell nuclei. PLoS ONE 9(9):e108346

Article  PubMed  PubMed Central  Google Scholar 

Goldani AA, Downs SR, Widjaja F, Lawton B, Hendren RL (2014) Biomarkers in autism. Front Psychiatry 5:100

Article  PubMed  PubMed Central  Google Scholar 

Graves JA, Metukuri M, Scott D, Rothermund K, Pro